Sanofi (EPA:SAN)
81.65
+0.31 (0.38%)
Aug 12, 2025, 5:36 PM CET
Sanofi Employees
Sanofi had 82,878 employees as of December 31, 2024. The number of employees decreased by 3,210 or -3.73% compared to the previous year.
Employees
82,878
Change (1Y)
-3,210
Growth (1Y)
-3.73%
Revenue / Employee
$551,871
Profits / Employee
$110,114
Market Cap
99.57B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
Dec 31, 2020 | 99,412 | -997 | -0.99% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 153,498 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 14,754 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
ABIVAX Société Anonyme | 69 |
Virbac | 6,365 |
emeis Société anonyme | 83,494 |
Sanofi News
- 13 hours ago - UK Government, Eli Lilly Partner To Target Obesity Health Gaps - Benzinga
- 14 hours ago - Sanofi reportedly halts sales of cholesterol drug Praluent in China amid limited availability - Seeking Alpha
- 18 hours ago - Sanofi stops supply of high cholesterol drug to China due to limited availability - Reuters
- 5 days ago - Sanofi: Playing To Win - Seeking Alpha
- 5 days ago - Emcure Pharmaceuticals Reports Strong Q1 FY26 Results with 16% Revenue Growth and 41% Jump in Profit - Business Upturn
- 6 days ago - Novavax raises 2025 revenue target to $1.05B with milestone payments and streamlined expenses as Sanofi partnership progresses - Seeking Alpha
- 6 days ago - Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc. - GlobeNewsWire
- 8 days ago - What's Driving the Market Sentiment Around Sanofi? - Benzinga